Upfront surgery is essential in selected patients with stage IIIA non-small cell lung cancer.
作者信息
Zheng Difan, Chen Haiquan
机构信息
Department of Thoracic Surgery, Fudan University Shanghai Cancer Center, Shanghai 200032, China.
Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China.
出版信息
J Thorac Dis. 2018 Dec;10(12):E815-E816. doi: 10.21037/jtd.2018.11.69.
Abstract
摘要
相似文献
1
Upfront surgery is essential in selected patients with stage IIIA non-small cell lung cancer.对于部分ⅢA期非小细胞肺癌患者， upfront手术至关重要。 （注：这里“upfront”可能在医学语境中有特定含义，比如“初次的、前期的”等，具体需结合专业知识进一步理解其准确意思。）
J Thorac Dis. 2018 Dec;10(12):E815-E816. doi: 10.21037/jtd.2018.11.69.
2
Comparison of mediastinal lymph node status and relapse pattern in clinical stage IIIA non-small cell lung cancer patients treated with neoadjuvant chemotherapy versus upfront surgery: A single center experience.新辅助化疗与 upfront 手术治疗 IIIA 期非小细胞肺癌患者纵隔淋巴结状态和复发模式的比较：单中心经验。
Thorac Cancer. 2017 Sep;8(5):393-401. doi: 10.1111/1759-7714.12447. Epub 2017 Jul 3.
3
Upfront surgery as first-line therapy in selected patients with stage IIIA non-small cell lung cancer.对于特定的 IIIA 期非小细胞肺癌患者， upfront 手术作为一线治疗方法。
J Thorac Cardiovasc Surg. 2018 Apr;155(4):1814-1822.e4. doi: 10.1016/j.jtcvs.2017.10.075. Epub 2017 Nov 3.
4
Editorial on "upfront surgery as first-line therapy in selected patients with stage IIIA non-small cell lung cancer".关于“对部分ⅢA期非小细胞肺癌患者采用 upfront 手术作为一线治疗方案”的社论
J Thorac Dis. 2018 Jul;10(Suppl 18):S2192-S2194. doi: 10.21037/jtd.2018.06.154.
5
[Treatment outcome of locally advanced stage IIIA/B lung cancer].[局部晚期IIIA/B期肺癌的治疗结果]
Medicina (Kaunas). 2009;45(6):452-9.
6
N2-IIIA non-small cell lung cancer: a plea for surgery!N2-IIIA期非小细胞肺癌：呼吁手术治疗！
J Thorac Dis. 2016 Nov;8(Suppl 11):S849-S854. doi: 10.21037/jtd.2016.09.34.
7
Phase III Study of Surgery Versus Definitive Concurrent Chemoradiotherapy Boost in Patients With Resectable Stage IIIA(N2) and Selected IIIB Non-Small-Cell Lung Cancer After Induction Chemotherapy and Concurrent Chemoradiotherapy (ESPATUE).诱导化疗和同期放化疗后可切除 IIIA(N2)和部分 IIIB 期非小细胞肺癌患者的手术与根治性同期放化疗增敏的 III 期研究（ESPATUE）
J Clin Oncol. 2015 Dec 10;33(35):4194-201. doi: 10.1200/JCO.2015.62.6812. Epub 2015 Nov 2.
8
9
[Survival Analysis of 121 Stage N2-IIIa Non-small Cell Lung Cancer Patients
Treated with Surgery].121例接受手术治疗的N2-IIIa期非小细胞肺癌患者的生存分析
Zhongguo Fei Ai Za Zhi. 2015 Aug;18(8):505-11. doi: 10.3779/j.issn.1009-3419.2015.08.06.
10
Efficacy of surgery and prophylactic cranial irradiation in stage II and III small cell lung cancer.手术及预防性颅脑照射在II期和III期小细胞肺癌中的疗效
J Cancer. 2018 Sep 8;9(19):3500-3506. doi: 10.7150/jca.26157. eCollection 2018.
本文引用的文献
1
Predicting prognosis of post-chemotherapy patients with resected IIIA non-small cell lung cancer.预测接受化疗的 IIIA 期非小细胞肺癌切除术后患者的预后。
J Thorac Dis. 2018 Jul;10(7):4186-4194. doi: 10.21037/jtd.2018.06.160.
2
Upfront surgery as first-line therapy in selected patients with stage IIIA non-small cell lung cancer.对于特定的 IIIA 期非小细胞肺癌患者， upfront 手术作为一线治疗方法。
J Thorac Cardiovasc Surg. 2018 Apr;155(4):1814-1822.e4. doi: 10.1016/j.jtcvs.2017.10.075. Epub 2017 Nov 3.
3
Against the tide.逆势而行。
J Thorac Cardiovasc Surg. 2018 Apr;155(4):1823-1824. doi: 10.1016/j.jtcvs.2017.10.120. Epub 2017 Nov 6.
Zotero 插件